Study to Assess the Efficacy and Safety of LX201 for Prevention of Corneal Allograft Rejection Episodes and Graft Failure in Subjects at Increased Immunological Risk
Clinical trial NCT00447187 · TERMINATED
Trial details
- NCT number
- NCT00447187
- Sponsor
- Lux Biosciences, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-04-01
- Primary completion
- 2009-03-01
- Enrollment
- 368
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.